Harry Snady

2.2k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Harry Snady is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Harry Snady has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 16 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Harry Snady's work include Pancreatic and Hepatic Oncology Research (13 papers), Gastric Cancer Management and Outcomes (8 papers) and Pancreatitis Pathology and Treatment (7 papers). Harry Snady is often cited by papers focused on Pancreatic and Hepatic Oncology Research (13 papers), Gastric Cancer Management and Outcomes (8 papers) and Pancreatitis Pathology and Treatment (7 papers). Harry Snady collaborates with scholars based in United States, Canada and China. Harry Snady's co-authors include Gary S. Bochna, Joseph P. Moore, John G. Lee, James A. DiSario, Michael E. Ryan, Carol Overby, Martin L. Freeman, Douglas B. Nelson, Fennerty Mb and Robert V. Erickson and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and European Journal of Cancer.

In The Last Decade

Harry Snady

30 papers receiving 1.5k citations

Hit Papers

Risk factors for post-ERCP pancreatitis: A prospective, m... 2001 2026 2009 2017 2001 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harry Snady United States 13 1.4k 1.2k 963 133 123 31 1.6k
T Topalidis Germany 14 724 0.5× 693 0.6× 505 0.5× 171 1.3× 73 0.6× 30 1.1k
T Perniceni France 18 1.6k 1.2× 1.2k 1.0× 584 0.6× 91 0.7× 389 3.2× 65 1.9k
Akihiko Horiguchi Japan 18 866 0.6× 635 0.5× 693 0.7× 128 1.0× 64 0.5× 90 1.2k
Rajeev Attam United States 21 1.2k 0.8× 646 0.5× 928 1.0× 130 1.0× 67 0.5× 54 1.3k
G.G. Ginsberg United States 13 925 0.7× 516 0.4× 495 0.5× 90 0.7× 77 0.6× 27 1.0k
Kyo-Sang Yoo South Korea 17 662 0.5× 634 0.5× 389 0.4× 93 0.7× 62 0.5× 40 994
R Hintze Germany 14 1.4k 1.0× 846 0.7× 757 0.8× 72 0.5× 158 1.3× 25 1.5k
Yun Nah Lee South Korea 21 892 0.7× 905 0.7× 584 0.6× 152 1.1× 126 1.0× 110 1.2k
Tsafrir Vanounou Canada 14 728 0.5× 411 0.3× 692 0.7× 131 1.0× 140 1.1× 22 990
Chung Ngai Tang China 20 920 0.7× 591 0.5× 560 0.6× 122 0.9× 466 3.8× 40 1.3k

Countries citing papers authored by Harry Snady

Since Specialization
Citations

This map shows the geographic impact of Harry Snady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Snady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Snady more than expected).

Fields of papers citing papers by Harry Snady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harry Snady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Snady. The network helps show where Harry Snady may publish in the future.

Co-authorship network of co-authors of Harry Snady

This figure shows the co-authorship network connecting the top 25 collaborators of Harry Snady. A scholar is included among the top collaborators of Harry Snady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harry Snady. Harry Snady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Snady, Harry. (2023). Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation. Annals of Medicine. 55(1). 1256–1264. 2 indexed citations
2.
Cooperman, Avram M., Howard W. Bruckner, Harry Snady, et al.. (2017). Cancer of the Pancreas—Actual 5, 10, and 20+Year Survival. Surgical Clinics of North America. 98(1). 73–85. 6 indexed citations
3.
Perdue, David G., Martin L. Freeman, James A. DiSario, et al.. (2008). Plastic Versus Self-expanding Metallic Stents for Malignant Hilar Biliary Obstruction. Journal of Clinical Gastroenterology. 42(9). 1040–1046. 131 indexed citations
4.
Snady, Harry. (2002). Interventional endoscopy, and neoadjuvant therapy and the gastroenterologist. Hematology/Oncology Clinics of North America. 16(1). 53–79. 8 indexed citations
5.
Cooperman, Avram M., et al.. (2001). LONG-TERM FOLLOW-UP OF TWENTY PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS. Surgical Clinics of North America. 81(3). 699–708. 9 indexed citations
6.
Freeman, Martin L., James A. DiSario, Douglas B. Nelson, et al.. (2001). Risk factors for post-ERCP pancreatitis: A prospective, multicenter study. Gastrointestinal Endoscopy. 54(4). 425–434. 883 indexed citations breakdown →
7.
Snady, Harry. (2001). Endoscopic Ultrasonography in Benign Pancreatic Disease. Surgical Clinics of North America. 81(2). 329–344. 12 indexed citations
8.
Snady, Harry, et al.. (2001). Outcomes trial demonstrating a survival advantage of initial chemoradiotherapy for regional pancreatic adenocarcinoma (PCa). European Journal of Cancer. 37. S253–S254. 2 indexed citations
9.
Freeman, Martin L., David Nelson, James A. DiSario, et al.. (1998). Outcomes of pancreatic therapeutic ERCP as compared with biliary therapeutic and diagnostic ERCP: A prospective multisite study. Gastrointestinal Endoscopy. 47(4). 1 indexed citations
10.
Freeman, Martin L., David Nelson, GM Eisen, et al.. (1998). Failures and complications of attempted therapeutic ERCP: Impact on outcomes and costs. Gastrointestinal Endoscopy. 47(4). 4 indexed citations
11.
Snady, Harry, et al.. (1998). Improving the Treatment of Colorectal Cancer: The Role of EUS. Cancer Investigation. 16(8). 572–581. 13 indexed citations
12.
Altorki, Nasser K., Harry Snady, & David B. Skinner. (1996). Endosonography for cancer of the esophagus and cardia: is it worthwhile?. Diseases of the Esophagus. 6 indexed citations
13.
Snady, Harry. (1995). Pancreatic Cancer: Influence of Endoscopic Ultrasonography on Management and Outcomes. Gastrointestinal Endoscopy Clinics of North America. 5(4). 755–762. 8 indexed citations
14.
Snady, Harry, et al.. (1994). Endoscopic ultrasonographic criteria of vascular invasion by potentially resectable pancreatic tumors. Gastrointestinal Endoscopy. 40(3). 326–333. 84 indexed citations
15.
Bruckner, Howard W., Shalom Kalnicki, Jack Dalton, et al.. (1993). Survival After Combined Modality Therapy for Pancreatic Cancer. Journal of Clinical Gastroenterology. 16(3). 199–203. 22 indexed citations
16.
Snady, Harry, Avram M. Cooperman, & Jerome H. Siegel. (1992). Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peri-pancreatic mass. Gastrointestinal Endoscopy. 38(1). 27–34. 86 indexed citations
17.
Snady, Harry. (1992). Endoscopic ultrasonography: an effective new tool for diagnosing gastrointestinal tumors.. PubMed. 6(7). 63–74; discussion 77. 11 indexed citations
18.
Snady, Harry, Alan S. Rosman, & Mark A. Korsten. (1989). Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices. Gastrointestinal Endoscopy. 35(5). 377–380. 15 indexed citations
19.
Snady, Harry. (1987). The role of sclerotherapy in the treatment of esophageal varices: personal experience and a review of randomized trials.. PubMed. 82(9). 813–22. 27 indexed citations
20.
Jh, Siegel & Harry Snady. (1986). The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma of the pancreas: results of nonoperative decompression in 277 patients.. PubMed. 81(8). 634–41. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026